GI
$133.73
-0.63
(-0.47%)
As of May 26, 2026, 8:53 PM EDT
Gilead Sciences (GILD) is trading down at $133.73 (-0.47%) on NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.
About Gilead Sciences
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
Recent News (4)
-
Maxim Upgrades Gilead Sciences (GILD) to ‘Buy’ Maxim Upgrades Gilead Sciences (GILD) to ‘Buy’
-
Gilead wins FDA approval for first hepatitis delta treatment Gilead wins FDA approval for first hepatitis delta treatment
-
Gilead Sciences stock rises after FDA approves HDV treatment Gilead Sciences stock rises after FDA approves HDV treatment
-
Gilead Sciences (GILD) Is Among The Best Extremely Profitable Stocks To Buy According To Wall Street Analysts Gilead Sciences (GILD) Is Among The Best Extremely Profitable Stocks To Buy According To Wall Street Analysts